Compare · JMG vs STE
JMG vs STE
Side-by-side comparison of JM Group Limited (JMG) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- JMG operates in Consumer Discretionary, while STE operates in Health Care - the two are in different parts of the market.
- STE carries a market cap of $21.75B.
- Over the past year, JMG is up 20.9% and STE is down 1.5% - JMG leads by 22.4 points.
- STE has been more active in the news (3 items in the past 4 weeks vs 2 for JMG).
- STE has more recent analyst coverage (16 ratings vs 0 for JMG).
- Company
- JM Group Limited
- STERIS plc (Ireland)
- Price
- $6.76-5.72%
- $221.72-0.76%
- Market cap
- -
- $21.75B
- 1M return
- +0.00%
- -0.80%
- 1Y return
- +20.93%
- -1.52%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- AMEX
- NYSE
- IPO
- 2025
- News (4w)
- 2
- 3
- Recent ratings
- 0
- 16
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest JMG
- SEC Form 3 filed by new insider Li Sze Wai
- SEC Form 3 filed by new insider Ting Chun Kwok Stanley
- SEC Form 3 filed by new insider Zheng Kin
- SEC Form 3 filed by new insider Ting Rita
- SEC Form 6-K filed by JM Group Limited
- JM Group Limited Provides Update Regarding Trading Halt of its Securities
- SEC Form 20-F filed by JM Group Limited
- SEC Form 6-K filed by JM Group Limited
- SEC Form NT 20-F filed by JM Group Limited
- SEC Form 6-K filed by JM Group Limited
Latest STE
- STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026
- Teleflex Announces Governance Updates
- SEC Form 8-K filed by STERIS plc (Ireland)
- Amendment: SEC Form SCHEDULE 13G/A filed by STERIS plc (Ireland)
- Director Feldmann Cynthia L exercised 3,098 units of Ordinary Shares at a strike of $152.32 and sold $734,877 worth of Ordinary Shares (3,098 units at $237.21) (SEC Form 4)
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 10-Q filed by STERIS plc (Ireland)
- STERIS plc (Ireland) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- STERIS Announces Financial Results for Fiscal 2026 Third Quarter
- STERIS Announces Dividend of $0.63 per share